NeuroMetrix, Inc. (NURO)
May 1, 2025 - NURO was delisted (reason: acquired by ECOR)
4.580
0.00 (0.00%)
Inactive · Last trade price on May 1, 2025

Company Description

NeuroMetrix, Inc., a commercial stage neurotechnology company, engages in designing and sale of medical devices.

Its marketed products include DPNCheck, a nerve conduction test that is used to evaluate peripheral neuropathies, such as diabetic peripheral neuropathy; and Quell, a wearable device for symptomatic relief and management of chronic pain.

The company offers its products to managed endocrinologists, podiatrists, primary care physicians, and other clinicians at the point-of care to objectively detect, stage, and monitor peripheral neuropathies.

NeuroMetrix, Inc. was incorporated in 1996 and is headquartered in Woburn, Massachusetts.

NeuroMetrix, Inc.
NeuroMetrix logo
CountryUnited States
Founded1996
IndustryMedical Devices
SectorHealthcare
Employees13
CEOShai Gozani

Contact Details

Address:
4B Gill Street
Woburn, Massachusetts 01801
United States
Phone781 890 9989
Websiteneurometrix.com

Stock Details

Ticker SymbolNURO
ExchangeNASDAQ
Stock TypeCommon Stock
Fiscal YearJanuary - December
Reporting CurrencyUSD
CIK Code0001289850
CUSIP Number641255807
ISIN NumberUS6412558800
Employer ID04-3308180
SIC Code3841